![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/veloxis-pharmaceuticals-announces-dosing-of-the-first-patient-by-partner-xenikos-in-the-global-phase-3-study-evaluating-t-guard-in-patients-with-steroid-refractory-acute-graft-versus-host-disease-sr-agvhd-301576083.html
https://www.globenewswire.com/news-release/2022/06/27/2469339/0/en/Xenikos-Enrolls-First-Patient-in-Global-Pivotal-Phase-3-Study-Evaluating-T-Guard-in-Patients-with-Steroid-Refractory-Acute-Graft-Versus-Host-Disease.html
https://www.globenewswire.com/news-release/2021/09/22/2301164/0/en/Xenikos-Appoints-Hassan-Aly-MD-PhD-as-Chief-Medical-Officer.html